找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bronchopulmonary Dysplasia; Vineet Bhandari Book 2016 Springer International Publishing Switzerland 2016 bronchopulmonary dysplasia.chroni

[復(fù)制鏈接]
樓主: fungus
41#
發(fā)表于 2025-3-28 15:36:30 | 只看該作者
42#
發(fā)表于 2025-3-28 19:37:11 | 只看該作者
43#
發(fā)表于 2025-3-29 00:31:15 | 只看該作者
Noninvasive Ventilation for the Prevention of Bronchopulmonary Dysplasiated via an endotracheal tube. Although there have been improvements in ventilator design and techniques of ventilation (synchronization, volume targeting) as well as the development of proven effective therapies such as exogenous surfactant, clinicians now seek to avoid or at least minimize exposure
44#
發(fā)表于 2025-3-29 06:16:30 | 只看該作者
45#
發(fā)表于 2025-3-29 10:09:05 | 只看該作者
46#
發(fā)表于 2025-3-29 14:03:46 | 只看該作者
Pulmonary Hypertension in Bronchopulmonary Dysplasiay, mortality, and healthcare expenditure. Despite many recent clinical advances, pulmonary vascular disease (PVD) remains an important contributor to poor outcomes in BPD. Understanding the relationship between BPD and PH and identifying optimal therapies may help minimize morbidity and improve outc
47#
發(fā)表于 2025-3-29 17:54:41 | 只看該作者
Pulmonary Function in Survivors of Bronchopulmonary Dysplasiarity and are now reaching adulthood in ever increasing numbers. The impact of preterm birth and its respiratory complications have lasting consequences on respiratory health. Bronchopulmonary dysplasia (BPD) and the long-term respiratory consequences of prematurity are unfamiliar and under-recognize
48#
發(fā)表于 2025-3-29 22:50:57 | 只看該作者
49#
發(fā)表于 2025-3-30 00:27:46 | 只看該作者
Respiratory Medicinehttp://image.papertrans.cn/b/image/191293.jpg
50#
發(fā)表于 2025-3-30 04:05:15 | 只看該作者
Pulmonary Hypertension in Bronchopulmonary Dysplasiay, mortality, and healthcare expenditure. Despite many recent clinical advances, pulmonary vascular disease (PVD) remains an important contributor to poor outcomes in BPD. Understanding the relationship between BPD and PH and identifying optimal therapies may help minimize morbidity and improve outcomes.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 16:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
姜堰市| 密云县| 中牟县| 双城市| 临颍县| 威信县| 宜兰市| 龙川县| 固阳县| 聂荣县| 宜章县| 达拉特旗| 竹溪县| 辛集市| 璧山县| 桂阳县| 陵水| 汝州市| 新民市| 皋兰县| 隆回县| 三明市| 莱阳市| 连江县| 边坝县| 建湖县| 泰宁县| 满洲里市| 岳阳市| 金沙县| 贡山| 保德县| 民乐县| 比如县| 武陟县| 澄迈县| 临沧市| 凌云县| 赤壁市| 资源县| 民和|